These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 22231634

  • 1. Radiotherapy with and without temozolomide in elderly patients with glioblastoma.
    Niyazi M, Schwarz SB, Suchorska B, Belka C.
    Strahlenther Onkol; 2012 Feb; 188(2):154-9. PubMed ID: 22231634
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
    Ishikawa E, Muragaki Y, Yamamoto T, Maruyama T, Tsuboi K, Ikuta S, Hashimoto K, Uemae Y, Ishihara T, Matsuda M, Matsutani M, Karasawa K, Nakazato Y, Abe T, Ohno T, Matsumura A.
    J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
    Biau J, Chautard E, De Schlichting E, Dupic G, Pereira B, Fogli A, Müller-Barthélémy M, Dalloz P, Khalil T, Dillies AF, Durando X, Godfraind C, Verrelle P.
    Radiat Oncol; 2017 Dec 06; 12(1):197. PubMed ID: 29212499
    [Abstract] [Full Text] [Related]

  • 8. The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma.
    Park CK, Lee SH, Kim TM, Choi SH, Park SH, Heo DS, Kim IH, Jung HW.
    J Neurooncol; 2013 Apr 06; 112(2):277-83. PubMed ID: 23377829
    [Abstract] [Full Text] [Related]

  • 9. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma.
    Minniti G, De Sanctis V, Muni R, Rasio D, Lanzetta G, Bozzao A, Osti MF, Salvati M, Valeriani M, Cantore GP, Maurizi Enrici R.
    J Neurooncol; 2009 Jan 06; 91(1):95-100. PubMed ID: 18758912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials?
    Fiorentino A, Balducci M, De Bonis P, Chiesa S, De Filippo L, Mangiola A, De Rose F, Autorino R, Rinaldi C, Fersino S, Diletto B, Matteucci P, Ciurlia E, Fusco V, Anile C, Valentini V.
    Am J Clin Oncol; 2015 Feb 06; 38(1):23-7. PubMed ID: 23388566
    [Abstract] [Full Text] [Related]

  • 14. Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma.
    Gerstein J, Franz K, Steinbach JP, Seifert V, Fraunholz I, Weiss C, Rödel C.
    Radiother Oncol; 2010 Dec 06; 97(3):382-6. PubMed ID: 20850883
    [Abstract] [Full Text] [Related]

  • 15. Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials.
    Balducci M, Fiorentino A, De Bonis P, Chiesa S, Mangiola A, Mattiucci GC, D'Agostino GR, Frascino V, Mantini G, Alitto AR, Colosimo C, Anile C, Valentini V.
    Strahlenther Onkol; 2013 Nov 06; 189(11):926-31. PubMed ID: 23974823
    [Abstract] [Full Text] [Related]

  • 16. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.
    Gutenberg A, Bock HC, Reifenberger G, Brück W, Giese A.
    Acta Neurochir (Wien); 2013 Mar 06; 155(3):429-35. PubMed ID: 23254891
    [Abstract] [Full Text] [Related]

  • 17. Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide.
    Guler OC, Yıldırım BA, Önal C, Topkan E.
    Indian J Cancer; 2019 Mar 06; 56(1):59-64. PubMed ID: 30950447
    [Abstract] [Full Text] [Related]

  • 18. Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution.
    Gerstein J, Franz K, Steinbach JP, Seifert V, Rödel C, Weiss C.
    Strahlenther Onkol; 2011 Nov 06; 187(11):722-8. PubMed ID: 22037649
    [Abstract] [Full Text] [Related]

  • 19. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
    Malmström A, Poulsen HS, Grønberg BH, Stragliotto G, Hansen S, Asklund T, Holmlund B, Łysiak M, Dowsett J, Kristensen BW, Söderkvist P, Rosell J, Henriksson R, Nordic Clinical Brain Tumor Study Group (NCBTSG).
    Acta Oncol; 2017 Dec 06; 56(12):1776-1785. PubMed ID: 28675067
    [Abstract] [Full Text] [Related]

  • 20. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials.
    Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C.
    J Neurooncol; 2015 Jun 06; 123(2):251-7. PubMed ID: 25920710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.